Article Abstract

Use of novel oral anticoagulant agents in venous thromboembolism

Authors: Shivanshu Madan, Shenil Shah, Patrick Dale, Sasan Partovi, Sahil A. Parikh

Abstract

New oral anticoagulants (NOAC) serve as alternatives for patients currently using warfarin for the prevention and treatment of venous thromboembolic (VTE) disease. This article provides a brief summary of the clinical use of these drugs as well as a review of the landmark clinical trials which evaluated described their safety and efficacy. As more data becomes available, a fundamental understanding of these medications will be vital to cardiovascular practitioners managing patients with VTE.

Refbacks

  • There are currently no refbacks.

Article Options

Download Citation